Patient Guide: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 47 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06618287
Status: 🟢 Enrolling Now
Condition: Lung Cancer, Breast Cancer
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 47 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Miami, Florida
  • • Iowa City, Iowa
  • • And 44 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors - Join Clinical Trial NCTNCT06618287

How to Join This Clinical Trial - NCTNCT06618287

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Lung Cancer, Breast Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lung Cancer, Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lung Cancer, Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06618287 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 47 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294-3300 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Miami, Florida 33136 - United States

Status: RECRUITING

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hackensack, New Jersey 07601 - United States

Status: RECRUITING

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: RECRUITING

Clinical Research Site

Portland, Oregon 97239 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Pittsburgh, Pennsylvania 15232 - United States

Status: WITHDRAWN

Clinical Research Site

Seattle, Washington 98104 - United States

Status: RECRUITING

Clinical Research Site

Liverpool, New South Wales 2170 - Australia

Status: RECRUITING

Clinical Research Site

Woolloongabba, Queensland 4102 - Australia

Status: RECRUITING

And 37 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Lung Cancer, Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships